Open access · CC-BY
via OpenAlex
Telomere length and telomerase activity in osteoporosis and osteoarthritis (Review)
Persefoni Fragkiadaki, Dragana Nikitovic, Katerina Kalliantasi, Evangelia Sarandi, Maria Thanasoula, Polychronis D. Stivaktakis, Charitini� Nepka, Demetrios A. Spandidos, Tosounidis Theodoros, Aristidis Michael Tsatsakis
Experimental and Therapeutic Medicine · 2019 · ▲ 50 citations
Abstract
Osteoarthritis (OA) and osteoporosis (OP) are associated skeletal pathologies and have as a distinct feature the abnormal reconstruction of the subchondral bone. OA and OP have been characterized as age-related diseases and have been associated with telomere(definition) shortening and altered telomerase activity (TA). This review discusses the role of telomeres and telomerase in OA and OP pathologies and focuses on the usability of telomere length (TL) and the rate of telomere shortening as potential disease biomarkers. A number of studies have demonstrated that telomere shortening may contribute to OA and OP as an epigenetic factor. Therefore, it has been claimed that the measurement of TL of chondrocytes and/or peripheral blood cells may be an appropriate marker for the evaluation of the progression of these diseases. However, there is a need to be perform further studies with larger cohorts, with the aim of obtaining objective results and a better understanding of the association between TL, inflammation and aging, in order to provide further insight into the pathophysiology of degenerative joint diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3892/etm.2019.8370
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Fragkiadaki, P., Nikitovic, D., Kalliantasi, K., Sarandi, E., Thanasoula, M., Stivaktakis, P.D., Nepka, C., Spandidos, D.A., Theodoros, T., & Tsatsakis, A.M. (2019). Telomere length and telomerase activity in osteoporosis and osteoarthritis (Review). <em>Experimental and Therapeutic Medicine</em>. https://doi.org/10.3892/etm.2019.8370
Vancouver
Fragkiadaki P, Nikitovic D, Kalliantasi K, Sarandi E, Thanasoula M, Stivaktakis PD, et al. Telomere length and telomerase activity in osteoporosis and osteoarthritis (Review). Experimental and Therapeutic Medicine. 2019. doi:10.3892/etm.2019.8370.
BibTeX
@article{persefoni2019Telome,
title = {Telomere length and telomerase activity in osteoporosis and osteoarthritis (Review)},
author = {Persefoni Fragkiadaki and Dragana Nikitovic and Katerina Kalliantasi and Evangelia Sarandi and Maria Thanasoula and Polychronis D. Stivaktakis and Charitini� Nepka and Demetrios A. Spandidos and Tosounidis Theodoros and Aristidis Michael Tsatsakis},
journal = {Experimental and Therapeutic Medicine},
year = {2019},
doi = {10.3892/etm.2019.8370},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Hepatology 2004
Open access · OA
Telomeres and telomerase: A dual role in hepatocarcinogenesis
Clinical and Experimental Medicine 2025
Open access · CC-BY
The relationship between telomere length and aging-related diseases
Current Medicinal Chemistry 2022
Citation only
Telomere Length as a Marker of Biological Aging: A Critical Review of Recent Literature
Proceedings of the National Academy of Sciences 2008
Preprint · OA
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease
Cancers 2020
Open access · CC-BY
Telomeres and Telomere Length: A General Overview
International Journal of Molecular Sciences 2022
Open access · CC-BY